Issue 7, 2023

A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery

Abstract

A rectangle DNA origami nanostructure equipped with doxorubicin-derived prodrugs targeting a tumor cell-specific enzyme (NQO1) is constructed. Combining the high prodrug payload of DNA origami and NQO1-activated chemotherapy, this nanosystem presents therapeutic selectivity for NQO1-overexpressing MCF-7 cells over healthy L02 cells, offering a potent strategy for precision cancer therapy.

Graphical abstract: A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
24 Nov 2022
Accepted
21 Dec 2022
First published
21 Dec 2022

Chem. Commun., 2023,59, 912-915

A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery

Z. He, W. Xiang, Q. Fan, L. Wang and J. Chao, Chem. Commun., 2023, 59, 912 DOI: 10.1039/D2CC06367K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements